tiprankstipranks
Chesnara PLC (GB:CSN)
LSE:CSN
Want to see GB:CSN full AI Analyst Report?

Chesnara (CSN) AI Stock Analysis

81 Followers

Top Page

GB:CSN

Chesnara

(LSE:CSN)

Select Model
Select Model
Select Model
Neutral 53 (OpenAI - 5.2)
Rating:53Neutral
Price Target:
312.00 p
▲(0.00% Upside)
Action:DowngradedDate:03/25/26
The score is held back primarily by inconsistent profitability and especially unstable cash flow, despite a currently strong balance sheet. Technically, the stock shows a weak trend (below key moving averages and negative MACD), while valuation is supported by a very high dividend yield but tempered by negative earnings (negative P/E).
Positive Factors
Strong balance sheet / low leverage
Material deleveraging in 2025 leaves Chesnara with meaningful capitalization and regulatory headroom. Low reported debt versus sizeable equity supports acquisition optionality, dividend resilience and shock absorption for long-duration liabilities, improving strategic flexibility over months.
Negative Factors
Unstable cash generation
Repeated negative operating/free cash flow undermines durable capital generation and constrains reinvestment or distributions. Variability in cash conversion increases refinancing or capital management risk and weakens ability to fund acquisitions or absorb asset-market shocks over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong balance sheet / low leverage
Material deleveraging in 2025 leaves Chesnara with meaningful capitalization and regulatory headroom. Low reported debt versus sizeable equity supports acquisition optionality, dividend resilience and shock absorption for long-duration liabilities, improving strategic flexibility over months.
Read all positive factors

Chesnara (CSN) vs. iShares MSCI United Kingdom ETF (EWC)

Chesnara Business Overview & Revenue Model

Company Description
Chesnara plc, together with its subsidiaries, engages in the life assurance and pension businesses primarily in the United Kingdom, the Netherlands, and Sweden. It operates through CA, Movestic, Waard Group, and Scildon segments. The company under...
How the Company Makes Money
Chesnara makes money primarily by managing life insurance and pension policy portfolios and earning the spread between the returns it generates on invested policyholder and shareholder assets and the amounts it pays out in claims, benefits, and po...

Chesnara Financial Statement Overview

Summary
Balance sheet strength is a clear positive (very low reported debt in 2025 vs. sizeable equity), but operating results are uneven. Revenue rebounded strongly, yet profitability turned negative in 2025 and margins have been thin in profitable years. Cash generation is the biggest weakness, with negative operating/free cash flow in multiple years and a sharp outflow in 2025.
Income Statement
52
Neutral
Balance Sheet
73
Positive
Cash Flow
34
Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue990.40M1.67B1.03B-720.40M1.50B
Gross Profit990.40M1.67B1.03B-1.29B1.49B
EBITDA48.50M49.70M31.40M-48.40M42.19M
Net Income-10.40M3.90M18.70M-33.70M27.29M
Balance Sheet
Total Assets14.58B12.76B12.13B11.14B9.42B
Cash, Cash Equivalents and Short-Term Investments145.30M138.00M146.00M204.60M70.09M
Total Debt205.30M206.20M209.30M213.23M49.46M
Total Liabilities14.01B12.44B11.77B10.81B8.96B
Stockholders Equity415.50M314.40M359.90M333.12M458.17M
Cash Flow
Free Cash Flow-231.70M37.80M-35.70M-80.43M20.69M
Operating Cash Flow-230.80M38.60M-34.90M-76.92M24.32M
Investing Cash Flow-900.00K5.00M29.50M52.05M-3.64M
Financing Cash Flow234.80M-49.70M-49.80M121.30M-52.25M

Chesnara Technical Analysis

Technical Analysis Sentiment
Positive
Last Price312.00
Price Trends
50DMA
294.38
Positive
100DMA
287.32
Positive
200DMA
272.02
Positive
Market Momentum
MACD
4.09
Negative
RSI
71.28
Negative
STOCH
97.56
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CSN, the sentiment is Positive. The current price of 312 is above the 20-day moving average (MA) of 289.03, above the 50-day MA of 294.38, and above the 200-day MA of 272.02, indicating a bullish trend. The MACD of 4.09 indicates Negative momentum. The RSI at 71.28 is Negative, neither overbought nor oversold. The STOCH value of 97.56 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:CSN.

Chesnara Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
67
Neutral
£853.35M53.66-15.72%12.19%
66
Neutral
£28.23B3.6526.87%1.56%61.45%78.24%
58
Neutral
£69.71M6.2525.08%9.33%-41.29%150.43%
53
Neutral
£705.55M-59.40-2.93%8.03%-40.13%-369.64%
51
Neutral
£345.04M-134.79-8.36%28.33%14.18%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:CSN
Chesnara
307.50
102.67
50.13%
GB:PRU
Prudential
1,117.00
328.09
41.59%
GB:SAGA
Saga plc
591.00
456.80
340.39%
GB:HSD
Hansard Global
50.60
7.98
18.72%
GB:PBEE
PensionBee Group PLC
146.50
-7.50
-4.87%

Chesnara Corporate Events

Business Operations and StrategyDelistings and Listing Changes
Chesnara Increases Share Capital Following Incentive Scheme Allotments
Neutral
Apr 17, 2026
Chesnara plc has issued and admitted to trading additional ordinary shares on the London Stock Exchange in connection with its 2023 short‑term and long‑term incentive schemes and its 2022 savings-related share option plan. The new allo...
Business Operations and StrategyDividendsFinancial DisclosuresRegulatory Filings and ComplianceShareholder Meetings
Chesnara Sets 2026 AGM Date as It Maintains Dividend Growth Track Record
Positive
Apr 9, 2026
Chesnara has scheduled its 2026 annual general meeting for 12 May in London and is encouraging shareholders to submit proxy votes electronically in advance, while also allowing questions to be sent ahead of time for direct response or publication ...
Business Operations and StrategyRegulatory Filings and Compliance
Chesnara Updates Market on Total Voting Rights and Share Capital
Neutral
Apr 1, 2026
Chesnara plc has confirmed that its issued share capital comprises 230,948,035 ordinary shares of 5 pence each, with no treasury shares, meaning the total number of voting rights in the company is 230,948,035. This updated voting rights figure pro...
Regulatory Filings and Compliance
Chesnara General Counsel and Associate Add to Holdings in FTSE 250 Insurer
Positive
Mar 31, 2026
Chesnara has disclosed that Group General Counsel and PDMR Emma Dawe, together with a closely associated person, Adam Murphy, have each acquired 857 Chesnara ordinary shares at 290p on 30 March 2026. Following these market purchases on the London ...
Regulatory Filings and Compliance
Chesnara CFO Increases Stake with Purchase of Additional Shares
Positive
Mar 27, 2026
Chesnara has disclosed that group chief financial officer Tom Howard, a person discharging managerial responsibilities, has acquired 6,713 ordinary shares in the company at 296p per share on 25 March 2026. Following this transaction, Howard’...
Executive/Board ChangesRegulatory Filings and Compliance
Chesnara Grants Long-Term Share Options to Senior Executives
Positive
Mar 27, 2026
Chesnara has granted nil-cost share options to four senior executives under its 2023 Short Term Incentive Scheme and Long Term Incentive Plan, in line with the directors’ remuneration policy approved by shareholders in 2023. Group CEO Steven...
Regulatory Filings and Compliance
Chesnara Executives Boost Holdings Through Incentive Scheme Share Deals
Positive
Mar 26, 2026
Chesnara has disclosed a series of share dealings by its top executives, with Group CEO Steve Murray exercising options under short- and long-term incentive plans and increasing his total interest to 477,399 shares, alongside additional share purc...
Business Operations and StrategyDividendsFinancial DisclosuresM&A TransactionsPrivate Placements and Financing
Chesnara boosts profits and dividend as major acquisitions transform scale
Positive
Mar 24, 2026
Chesnara reported strong 2025 full-year results, highlighting a 19% rise in Operating Capital Generation to £94m, a 30% increase in cash remittances to £58m, and a 42% jump in adjusted operating profit to £56m. The group’s sol...
Regulatory Filings and Compliance
Chesnara Confirms Total Voting Rights at 230.9 Million Shares
Neutral
Mar 3, 2026
Chesnara plc has reported that its issued share capital currently consists of 230,934,260 ordinary shares of 5p each, with no shares held in treasury, meaning each share carries one voting right. The disclosure, made under UK Market Abuse Regulati...
Business Operations and StrategyFinancial Disclosures
Chesnara Simplifies Financial Framework and Sets March Date for Full-Year Results
Neutral
Feb 27, 2026
Chesnara has unveiled an updated financial framework that simplifies how it reports performance, centring on the pillars of cash, capital and value, and introducing new alternative performance measures: Operating Capital Generation and Adjusted Op...
Business Operations and StrategyM&A Transactions
Chesnara to Buy Scottish Widows Europe in €110m Deal to Expand in Luxembourg
Positive
Feb 17, 2026
Chesnara has agreed to acquire Luxembourg-based Scottish Widows Europe SA, a closed life insurance business, from Scottish Widows for €110 million in cash, adding about €1.7 billion of assets under administration and some 46,000 polici...
Business Operations and StrategyDividendsM&A Transactions
Chesnara Completes Largest Acquisition with HSBC Life UK Deal
Positive
Feb 2, 2026
Chesnara plc has completed its acquisition of HSBC Life (UK) Limited, marking the company’s fifteenth and largest deal to date and significantly increasing its scale in the UK life insurance and pensions market. Management says the transacti...
Regulatory Filings and Compliance
Chesnara Confirms Total Voting Rights at 230.9 Million Shares
Neutral
Jan 30, 2026
Chesnara has confirmed that its issued share capital stands at 230,930,471 ordinary shares of 5p each, with no shares held in treasury, meaning the total number of voting rights in the company is 230,930,471. The disclosure, made in line with the ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 25, 2026